These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32755609)
21. Conditional inactivation of Npy1r gene in mice induces behavioural inflexibility and orbitofrontal cortex hyperactivity that are reversed by escitalopram. Longo A; Fadda M; Brasso C; Mele P; Palanza P; Nanavaty I; Bertocchi I; Oberto A; Eva C Neuropharmacology; 2018 May; 133():12-22. PubMed ID: 29353053 [TBL] [Abstract][Full Text] [Related]
22. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Sainsbury A; Schwarzer C; Couzens M; Herzog H Diabetes; 2002 Dec; 51(12):3420-7. PubMed ID: 12453895 [TBL] [Abstract][Full Text] [Related]
23. Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways. Lin S; Lin EJ; Boey D; Lee NJ; Slack K; During MJ; Sainsbury A; Herzog H Endocrinology; 2007 May; 148(5):2056-65. PubMed ID: 17272395 [TBL] [Abstract][Full Text] [Related]
24. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus. Lectez B; Jeandel L; El-Yamani FZ; Arthaud S; Alexandre D; Mardargent A; Jégou S; Mounien L; Bizet P; Magoul R; Anouar Y; Chartrel N Endocrinology; 2009 May; 150(5):2342-50. PubMed ID: 19164468 [TBL] [Abstract][Full Text] [Related]
25. Leptin and the hypothalamo-pituitary-adrenal stress axis. Roubos EW; Dahmen M; Kozicz T; Xu L Gen Comp Endocrinol; 2012 May; 177(1):28-36. PubMed ID: 22293575 [TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577 [TBL] [Abstract][Full Text] [Related]
27. Effects of estrous cycle and sex on the expression of neuropeptide Y Y1 receptor in discrete hypothalamic and limbic nuclei of transgenic mice. Martini M; Sica M; Gotti S; Eva C; Panzica GC Peptides; 2011 Jun; 32(6):1330-4. PubMed ID: 21514339 [TBL] [Abstract][Full Text] [Related]
28. Hypothalamic bHLH transcription factors are novel candidates in the regulation of energy balance. Nilaweera KN; Ellis C; Barrett P; Mercer JG; Morgan PJ Eur J Neurosci; 2002 Feb; 15(4):644-50. PubMed ID: 11886445 [TBL] [Abstract][Full Text] [Related]
29. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777 [TBL] [Abstract][Full Text] [Related]
30. Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. Raber J; Akana SF; Bhatnagar S; Dallman MF; Wong D; Mucke L J Neurosci; 2000 Mar; 20(5):2064-71. PubMed ID: 10684907 [TBL] [Abstract][Full Text] [Related]
31. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Shi YC; Lau J; Lin Z; Zhang H; Zhai L; Sperk G; Heilbronn R; Mietzsch M; Weger S; Huang XF; Enriquez RF; Baldock PA; Zhang L; Sainsbury A; Herzog H; Lin S Cell Metab; 2013 Feb; 17(2):236-48. PubMed ID: 23395170 [TBL] [Abstract][Full Text] [Related]
32. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression. Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913 [TBL] [Abstract][Full Text] [Related]
33. Adult exposure to tributyltin affects hypothalamic neuropeptide Y, Y1 receptor distribution, and circulating leptin in mice. Bo E; Farinetti A; Marraudino M; Sterchele D; Eva C; Gotti S; Panzica G Andrology; 2016 Jul; 4(4):723-34. PubMed ID: 27310180 [TBL] [Abstract][Full Text] [Related]
35. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of fasting-induced cAMP response element-mediated gene induction by leptin in neuropeptide Y neurons of the arcuate nucleus. Shimizu-Albergine M; Ippolito DL; Beavo JA J Neurosci; 2001 Feb; 21(4):1238-46. PubMed ID: 11160394 [TBL] [Abstract][Full Text] [Related]
37. A sexually dimorphic distribution of corticotropin-releasing factor receptor 1 in the paraventricular hypothalamus. Rosinger ZJ; Jacobskind JS; De Guzman RM; Justice NJ; Zuloaga DG Neuroscience; 2019 Jun; 409():195-203. PubMed ID: 31055007 [TBL] [Abstract][Full Text] [Related]
38. MARCKSL1 Regulates Spine Formation in the Amygdala and Controls the Hypothalamic-Pituitary-Adrenal Axis and Anxiety-Like Behaviors. Tanaka T; Shimizu S; Ueno M; Fujihara Y; Ikawa M; Miyata S EBioMedicine; 2018 Apr; 30():62-73. PubMed ID: 29580842 [TBL] [Abstract][Full Text] [Related]
39. Ablation of NPFFR2 in Mice Reduces Response to Single Prolonged Stress Model. Lin YT; Huang YL; Tsai SC; Chen JC Cells; 2020 Nov; 9(11):. PubMed ID: 33202667 [TBL] [Abstract][Full Text] [Related]
40. Fasting, leptin treatment, and glucose administration differentially regulate Y(1) receptor gene expression in the hypothalamus of transgenic mice. Zammaretti F; Panzica G; Eva C Endocrinology; 2001 Sep; 142(9):3774-82. PubMed ID: 11517153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]